Cencora, Inc. (cor)
COR Estimates
Public analyst price targets and consensus snapshot for Cencora, Inc.. Deeper estimate history and models are available in Vest Terminal.
| Last price | $312.28 |
| Analyst mean target | $369.31 |
| Analyst high target | $430.00 |
| Analyst low target | $330.00 |
| Upside vs mean target | 18.3% |
| Consensus recommendation | Buy |
| Number of analysts | 13 |
| Forward P/E | 15.77 |
Start Free — open COR in Vest Terminal
Access live data, filings, ownership, and analysis for Cencora, Inc..
Cencora, Inc. FAQ
What does Cencora, Inc. (COR) do?
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipmen…
What is COR's P/E ratio?
Cencora, Inc. has a trailing P/E of 23.36× based on publicly available market data.
Does COR pay a dividend?
Indicated dividend yield: 0.8%. Confirm ex-dates and payout history in Vest Terminal.
What sector is COR in?
Cencora, Inc. is classified in Healthcare (Medical Distribution) on NYQ.
What is COR's market capitalization?
Approximate market cap: $59.59B.
What are the main risks for COR?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of COR?
Potential positives include revenue growth of 5.1% year-over-year, earnings growth of 11.9% year-over-year.
Where can I get analyst estimates for COR?
Public analyst price targets and consensus for Cencora, Inc. are on the free /stocks/cor/estimates page. Deeper estimate history and models are available in Vest Terminal.